{"entity":{"type":"insider","cik":"0001712459","url":"/insider/0001712459","json_url":"/insider/0001712459.json","name":"BRYNELSEN CHARLES","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":5,"first":"2019-03-04","last":"2026-02-17","span_basis":"filed_date"},"name_variants":[{"name":"BRYNELSEN CHARLES","source":"filing","n_filings":5,"first_seen":"2019-03-04","last_seen":"2026-02-17"}],"transactions":[{"id":5780962,"accession":"0000914190-26-000025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914190-26-000025","line_url":"/filing/0000914190-26-000025#line-1","is_derivative":false,"issuer_cik":"0001712459","issuer_name":"Envoy Medical, Inc.","issuer_ticker":"COCH","issuer_name_source":null,"issuer_url":"/issuer/0001712459","owner_cik":"0001712459","owner_name":"BRYNELSEN CHARLES","owner_url":"/insider/0001712459","role":"Director","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000000.0,"shares_display":"1,000,000","price_per_share":0.4,"price_display":"0.40","price_state":"stated","total_value":400000.0,"total_display":"400,000.00","shares_owned_after":1050000.0,"shares_owned_after_display":"1,050,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-12","filed_date":"2026-02-17","scope":"insider"},{"id":4591657,"accession":"0001062993-25-010396","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-25-010396","line_url":"/filing/0001062993-25-010396#line-3","is_derivative":false,"issuer_cik":"0001712459","issuer_name":"Envoy Medical, Inc.","issuer_ticker":"COCH","issuer_name_source":null,"issuer_url":"/issuer/0001712459","owner_cik":"0001712459","owner_name":"BRYNELSEN CHARLES","owner_url":"/insider/0001712459","role":"Director","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35000.0,"shares_display":"35,000","price_per_share":1.6478,"price_display":"1.65","price_state":"stated","total_value":57673.0,"total_display":"57,673.00","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-27","filed_date":"2025-05-27","scope":"insider"},{"id":4591652,"accession":"0001062993-25-010396","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-25-010396","line_url":"/filing/0001062993-25-010396#line-2","is_derivative":false,"issuer_cik":"0001712459","issuer_name":"Envoy Medical, Inc.","issuer_ticker":"COCH","issuer_name_source":null,"issuer_url":"/issuer/0001712459","owner_cik":"0001712459","owner_name":"BRYNELSEN CHARLES","owner_url":"/insider/0001712459","role":"Director","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13000.0,"shares_display":"13,000","price_per_share":1.6433,"price_display":"1.64","price_state":"stated","total_value":21362.9,"total_display":"21,362.90","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-23","filed_date":"2025-05-27","scope":"insider"},{"id":4591647,"accession":"0001062993-25-010396","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-25-010396","line_url":"/filing/0001062993-25-010396#line-1","is_derivative":false,"issuer_cik":"0001712459","issuer_name":"Envoy Medical, Inc.","issuer_ticker":"COCH","issuer_name_source":null,"issuer_url":"/issuer/0001712459","owner_cik":"0001712459","owner_name":"BRYNELSEN CHARLES","owner_url":"/insider/0001712459","role":"Director","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":1.6834,"price_display":"1.68","price_state":"stated","total_value":3366.8,"total_display":"3,366.80","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-22","filed_date":"2025-05-27","scope":"insider"},{"id":4155784,"accession":"0001415889-21-001198","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-21-001198","line_url":"/filing/0001415889-21-001198#line-2","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001712459","owner_name":"BRYNELSEN CHARLES","owner_url":"/insider/0001712459","role":"Officer (SENIOR VICE PRESIDENT)","officer_title":"SENIOR VICE PRESIDENT","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1002.0,"shares_display":"1,002","price_per_share":120.61,"price_display":"120.61","price_state":"stated","total_value":120851.22,"total_display":"120,851.22","shares_owned_after":43550.0,"shares_owned_after_display":"43,550","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-02","scope":"insider"},{"id":2818866,"accession":"0001179110-20-002893","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-002893","line_url":"/filing/0001179110-20-002893#line-2","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001712459","owner_name":"BRYNELSEN CHARLES","owner_url":"/insider/0001712459","role":"Officer (Senior Vice President)","officer_title":"Senior Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1781.0,"shares_display":"1,781","price_per_share":77.89,"price_display":"77.89","price_state":"stated","total_value":138722.09,"total_display":"138,722.09","shares_owned_after":45460.0,"shares_owned_after_display":"45,460","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-02","filed_date":"2020-03-03","scope":"insider"},{"id":8157792,"accession":"0001179110-19-003111","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-19-003111","line_url":"/filing/0001179110-19-003111#line-2","is_derivative":false,"issuer_cik":"0000001800","issuer_name":"ABBOTT LABORATORIES","issuer_ticker":"ABT","issuer_name_source":null,"issuer_url":"/issuer/0000001800","owner_cik":"0001712459","owner_name":"BRYNELSEN CHARLES","owner_url":"/insider/0001712459","role":"Officer (Senior Vice President)","officer_title":"Senior Vice President","security_title":"Common shares without par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1002.0,"shares_display":"1,002","price_per_share":78.0,"price_display":"78.00","price_state":"stated","total_value":78156.0,"total_display":"78,156.00","shares_owned_after":41111.0,"shares_owned_after_display":"41,111","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-01","filed_date":"2019-03-04","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001840877","name":"Envoy Medical, Inc.","url":"/issuer/0001840877","role":"Director","n_filings":2,"first_seen":"2025-05-27","last_seen":"2026-02-17"},{"type":"issuer","type_label":"ISSUER","cik":"0000001800","name":"ABBOTT LABORATORIES","url":"/issuer/0000001800","role":"Officer (SENIOR VICE PRESIDENT)","n_filings":3,"first_seen":"2019-03-04","last_seen":"2021-03-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001712459","retrieved_at":"2026-08-22T00:39:46+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}